RYR1 and myopathy: Especially challenging is to explain how both gain- and loss-of-function mutations in RYR1 lead to myopathies characterized by damage and destruction of mitochondria (that is, CCD and multi-minicore disease), formation of structural and contracture cores, and muscle weakness.